News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
766,547 Results
Type
Article (51458)
Company Profile (297)
Press Release (714776)
Multimedia
Podcasts (108)
Webinars (20)
Section
Business (212968)
Career Advice (2122)
Deals (36687)
Drug Delivery (137)
Drug Development (84112)
Employer Resources (174)
FDA (17310)
Job Trends (15836)
News (360946)
Policy (34936)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2821)
Accelerated approval (45)
Adcomms (30)
Allergies (171)
Alliances (51764)
ALS (205)
Alzheimer's disease (1827)
Antibody-drug conjugate (ADC) (434)
Approvals (17656)
Artificial intelligence (659)
Autoimmune disease (254)
Automation (53)
Bankruptcy (375)
Best Places to Work (12096)
BIOSECURE Act (20)
Biosimilars (215)
Biotechnology (191)
Bladder cancer (184)
Brain cancer (71)
Breast cancer (728)
Cancer (5712)
Cardiovascular disease (476)
Career advice (1808)
Career pathing (44)
CAR-T (317)
CDC (61)
Celiac Disease (2)
Cell therapy (838)
Cervical cancer (46)
Clinical research (72516)
Collaboration (2059)
Company closure (4)
Compensation (1333)
Complete response letters (80)
COVID-19 (2863)
CRISPR (102)
C-suite (1087)
Cystic fibrosis (150)
Data (7523)
Decentralized trials (3)
Denatured (39)
Depression (168)
Dermatology (71)
Diabetes (574)
Diagnostics (7110)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (309)
Drug pricing (207)
Drug shortages (34)
Duchenne muscular dystrophy (274)
Earnings (93496)
Editorial (69)
Employer branding (21)
Employer resources (153)
Events (124077)
Executive appointments (1084)
FDA (20968)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1707)
Gene editing (221)
Generative AI (62)
Gene therapy (684)
GLP-1 (1100)
Government (5006)
Grass and pollen (6)
Guidances (405)
Healthcare (20053)
HIV (79)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (285)
Immuno-oncology (89)
Indications (168)
Infectious disease (3206)
Inflammatory bowel disease (213)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (280)
Interviews (325)
IPO (17025)
IRA (51)
Job creations (4061)
Job search strategy (1509)
JPM (58)
Kidney cancer (18)
Labor market (96)
Layoffs (578)
Leadership (39)
Legal (8510)
Liver cancer (102)
Longevity (32)
Lung cancer (769)
Lymphoma (419)
Machine learning (58)
Management (59)
Manufacturing (998)
MASH (186)
Medical device (14928)
Medtech (15019)
Mergers & acquisitions (20874)
Metabolic disorders (1501)
mRNA (200)
Multiple sclerosis (183)
NASH (17)
Neurodegenerative disease (408)
Neuropsychiatric disorders (107)
Neuroscience (3324)
Neurotech (1)
NextGen: Class of 2026 (6922)
Non-profit (4786)
Now hiring (75)
Obesity (711)
Opinion (302)
Ovarian cancer (209)
Pain (249)
Pancreatic cancer (287)
Parkinson's disease (361)
Partnered (34)
Patents (570)
Patient recruitment (647)
Peanut (63)
People (62335)
Pharmaceutical (65)
Pharmacy benefit managers (33)
Phase 1 (22580)
Phase 2 (31858)
Phase 3 (23774)
Pipeline (7775)
Policy (318)
Postmarket research (2744)
Preclinical (9640)
Press Release (67)
Prostate cancer (291)
Psychedelics (56)
Radiopharmaceuticals (326)
Rare diseases (1047)
Real estate (6361)
Recruiting (70)
Regulatory (26684)
Reports (55)
Research institute (2577)
Resumes & cover letters (363)
Rett syndrome (34)
RNA editing (19)
RSV (91)
Schizophrenia (178)
Series A (279)
Series B (211)
Service/supplier (12)
Sickle cell disease (111)
Special edition (22)
Spinal muscular atrophy (170)
Sponsored (48)
Startups (3886)
State (2)
Stomach cancer (19)
Supply chain (131)
Tariffs (90)
The Weekly (67)
Vaccines (1123)
Venture capital (104)
Weight loss (473)
Women's health (123)
Worklife (20)
Date
Today (1)
Last 7 days (769)
Last 30 days (2726)
Last 365 days (30920)
2026 (10082)
2025 (30909)
2024 (36104)
2023 (41145)
2022 (52383)
2021 (57100)
2020 (55910)
2019 (48795)
2018 (36938)
2017 (33746)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (817)
Alabama (93)
Alaska (7)
Arizona (350)
Arkansas (16)
Asia (42806)
Australia (7061)
California (12783)
Canada (3654)
China (1336)
Colorado (559)
Connecticut (568)
Delaware (388)
Europe (93302)
Florida (1911)
Georgia (418)
Hawaii (3)
Idaho (66)
Illinois (1066)
India (88)
Indiana (588)
Iowa (23)
Japan (520)
Kansas (132)
Kentucky (49)
Louisiana (40)
Maine (75)
Maryland (1572)
Massachusetts (9187)
Michigan (362)
Minnesota (718)
Mississippi (7)
Missouri (146)
Montana (33)
Nebraska (29)
Nevada (142)
New Hampshire (90)
New Jersey (3419)
New Mexico (30)
New York (3385)
North Carolina (1696)
North Dakota (8)
Northern California (6347)
Ohio (379)
Oklahoma (24)
Oregon (42)
Pennsylvania (2578)
Puerto Rico (28)
Rhode Island (52)
South America (1201)
South Carolina (87)
South Dakota (2)
Southern California (5032)
Tennessee (207)
Texas (2043)
United States (45644)
Utah (383)
Vermont (1)
Virginia (306)
Washington D.C. (83)
Washington State (1055)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
766,547 Results for "aerin medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aerin Medical Announces Long-Term Study Demonstrating Sustained Relief for Nasal Airway Obstruction Symptoms
April 2, 2025
·
4 min read
Biotech Bay
Aerin Medical Announces Positive Two-year Outcomes from the VATRAC Trial of VivAer®
Aerin Medical Announces Positive Two-year Outcomes from the VATRAC Trial of VivAer .
February 8, 2024
·
5 min read
Biotech Bay
New Two-Year Results Show Sustained Improvement in Chronic Rhinitis Symptoms Following a Single Procedure with Aerin Medical’s RhinAer®
Aerin Medical Inc. today announced the publication of positive 24-month results from RHINTRAC, a randomized, sham-controlled clinical trial, in the International Forum of Allergy & Rhinology (IFAR).
February 29, 2024
·
5 min read
Business
Derrick Sung Joins Aerin Medical as Chief Financial Officer
Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat physicians with non-invasive solutions for the treatment of chronic nasal conditions, announced that Derrick Sung has been appointed chief financial officer of the company.
November 20, 2023
·
3 min read
Press Releases
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026
April 23, 2026
·
17 min read
Biotech Bay
Aerin Medical Announces Advances for Chronic Rhinitis Treatment with New CPT® Code and Final CMS-Established Payment Rates
Aerin Medical Inc. announced that the Centers for Medicare and Medicaid Services assigned payment for a new Category I Current Procedural Terminology code for endoscopic destruction of the posterior nasal nerve using radiofrequency ablation.
November 3, 2023
·
4 min read
Biotech Bay
Aerin Medical Announces Sustained Clinical and Quality-of-Life Improvements Two Years After Chronic Rhinitis Treatment with RhinAer®
Aerin Medical Announces Sustained Clinical and Quality-of-Life Improvements Two Years After Chronic Rhinitis Treatment with RhinAer ®.
December 5, 2023
·
5 min read
Press Releases
Medical Care Technologies Inc. (OTC PINK:MDCE) Highlights Execution Momentum and Expanding AI Pipeline Following Strategic Growth Initiative
April 24, 2026
·
2 min read
Biotech Bay
Aerin Medical Announces New Positive Two-Year Results from VivAer® AERWAY Study
Aerin Medical Inc. today announced the publication of positive two-year follow-up data from the AERWAY trial for patients with severe or extreme nasal airway obstruction (NAO) due to nasal valve collapse (NVC).
July 13, 2023
·
6 min read
Press Releases
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
March 30, 2026
·
7 min read
1 of 76,655
Next
